Table 1.

Effect of Thrombin and TRAP of the PAR-1 Thrombin Receptor on Pulmonary Metastasis of B16F10 Melanoma

Group Median No. of Nodules (range) Median Nodule Volume (μL; range) Tumor Mass (μL)Fold Increase P
Experiment 1 (n = 12) 
 Control  1.5 (0-7)  0.6 (0-6)  0.9  
 Thrombin 7 (2-10)  5.7 (1-15)  40.0  44  .02  
 100 μmol/L 13-mer control peptide  2.5 (0-9) 2.3 (0-15)  5.8   NS  
 100 μmol/L 14-mer TRAP  5.5 (0-14)  7.9 (0-39)  43.5  48 (8)§ .02 (0.03)* 
Experiment 2 (n = 5)  
 SALLRN 7 (2-14)  19.9 (2-59)  139  
 SFLLRN 26 (13-31)  219 (131-353)  5,694  41  .04  
Group Median No. of Nodules (range) Median Nodule Volume (μL; range) Tumor Mass (μL)Fold Increase P
Experiment 1 (n = 12) 
 Control  1.5 (0-7)  0.6 (0-6)  0.9  
 Thrombin 7 (2-10)  5.7 (1-15)  40.0  44  .02  
 100 μmol/L 13-mer control peptide  2.5 (0-9) 2.3 (0-15)  5.8   NS  
 100 μmol/L 14-mer TRAP  5.5 (0-14)  7.9 (0-39)  43.5  48 (8)§ .02 (0.03)* 
Experiment 2 (n = 5)  
 SALLRN 7 (2-14)  19.9 (2-59)  139  
 SFLLRN 26 (13-31)  219 (131-353)  5,694  41  .04  

TRAP refers to 14 mer-SFLLRNPNDKYEPF or 6 mer-SFLLRN. Fifty thousand viable B16F10 cells were treated with either buffer, 1 U mL thrombin, 100 μmol/L TRAP, or 100 μmol/L control peptides, 13 mer SDEALPLGSPRCD, or 6 mer SALLRN for 60 minutes at 37°C. Cells were then washed three times with PBS-Ca-Mg-0.1 BSA before intravenous injection into the tail vein of syngeneic mice. Pulmonary metastases were examined macroscopically on day 21 for experiment 1 and on day 35 for experiment 2. n refers to number of animals in each subset of the experiment. P value refers to significance of the fold increase in tumor mass compared with control, determined by Wilcoxon Rank Sum test. The SEM is given.

Abbreviation: NS, not significant.

*

The number in parentheses refers to the increase over control peptide, with P value.

Close Modal

or Create an Account

Close Modal
Close Modal